Eric
Lv7
3870 积分
2022-07-04 加入
-
中国心力衰竭诊断和治疗指南2024
25天前
已完结
-
Efficacy and safety of glucagon-like-peptide-1 receptor agonists on body weight and cardiometabolic parameters in individuals with obesity and without diabetes: A systematic review and meta-analysis
25天前
已关闭
-
临床药代动力学与药效动力学 第4版
1个月前
已关闭
-
Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthma
1个月前
已完结
-
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
1个月前
已完结
-
Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe Asthma
1个月前
已完结
-
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
1个月前
已完结
-
Expert Scientific Group on Phase One Clinical Trials: Final Report
1个月前
已完结
-
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
1个月前
已完结
-
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
1个月前
已完结